
NOVARTIS – DERMATOLOGY WEBINAR
April 30 @ 6:30 pm - 8:00 pm
Meeting Objectives
- To provide an overview of IL-17 and its implications
- To highlight the diagnosis and management of Hidradenitis Suppurativa
Programme
6:30pm – 6:35pm Welcome & Greetings– Mrs. Janice Simpson-Spencer – Novartis Country Manager
6:35pm– 6:40pm Introduction of Moderator – Mrs Sophia McKenzie – Novartis Business Coordinator
6:40pm – 7:10pm Opening Remarks and Presentation on the Multi-Modal IL 17 – Dr. Delansie Lawrence
7:10pm –7:15pm Questions & Answers
7:15pm – 7:20pm Introduction of Speaker – Moderator
7:20pm – 8:05 pm Presentation on The Diagnosis and Management of Hidradenitis Suppurativa – Dr. Rokeisha Clare-Kleinbussink – Consultant Dermatologist
8:05pm – 8:20 pm Questions and Answers
8:20pm – 8:25pm Vote of thanks – Mr. Jason Spence – Novartis Medical Representative